EUnetHTA and EMA take stock of their cooperation

The European Network for Health Technology Assessment (EUnetHTA) and the European Medicines Agency (EMA) have published a Technical Report on their achievements since 2017.   The report covers the latest phase of an open and successful collaboration that began in 2010, and demonstrated that the synergies between regulatory evaluation and health technology assessment (HTA) along […]

EUnetHTA-EMA April Meeting – minutes now available

We are pleased to publish the minutes for the EUnetHTA-EMA Bilateral meeting held online on 28 April, 2021. This meeting concluded the EMA/EUnetHTA work plan 2017-2021, and attendees celebrated the strengthening of successful collaboration through more than a decade of joint work. Access here: EUnetHTA-EMA Bilateral minutes – 28 April 2021

EMA-EUnetHTA Bilateral Meeting held today.

The concluding EMA-EUnetHTA Bilateral Meeting under Joint Action 3 was held online today, marking a fitting conclusion to another stage of regular ongoing collaboration that stretches back through all three Joint Actions to the first bilateral meetings in 2010. Participants reviewed the joint achievements under the EMA/EUnetHTA workplan 2017-2021, showcasing the value of their collective […]

EMA-EUnetHTA Bilateral – December 2020 minutes now available

We are please to publish the minutes from the EMA-EUnetHTA Bilateral meeting, held 16 December 2020 online. Thanks to all attendees, and the continuing joint work undertaken by this collaboration. Access here: EMA-EUnetHTA Bilateral Meeting Minutes – Dec 2020 Further details on collaboration with the EMA, together with past meeting minutes, can be found here.

Minutes of EMA/EUnetHTA virtual meeting

We are pleased to publish the minutes of the 13 July 2020 meeting held between the European Medicines Agency (EMA) and EUnetHTA. The meeting covered updates on EMA/EUnetHTA collaboration, JA3 final phase priorities, and 201-2021 Work Plan review, in addition to COVID-19 publication focus and other topics. Please access at this link: EMA-EUnetHTA July 2020 […]

EMA-EUnetHTA Bilateral Meeting July 2020 – minutes now available

We are pleased to publish the minutes of the 13 July 2020 meeting held between the European Medicines Agency (EMA) and EUnetHTA. The meeting covered updates on EMA/EUnetHTA collaboration, JA3 final phase priorities, and 201-2021 Work Plan review, in addition to COVID-19 publication focus and other topics. Please access at this link: EMA-EUnetHTA July 2020 […]

EMA-EUnetHTA Bilateral Meeting – November 2019 – documentation now available

The minutes from the EMA-EUnetHTA Bilateral Meeting, hosted by EUnetHTA at the Zorginstituut Nederland (ZIN) in Diemen, Netherlands, on 21st November, 2019, are now available for access. Topics discussed included a follow-up on registries, patient-reported outcomes as part of evidence generation plans, PLEG, and more. In addition, a review on EMA-EUnetHTA activities in the context […]

Minutes from the EMA-EUnetHTA July 2019 Meeting now available

The minutes from the EMA-EUnetHTA Bilateral Meeting, hosted by the EUnetHTA at the Zorginstituut Nederland (ZIN) in Diemen, Netherlands, on 4th July, 2019, are now available for access. Topics discussed included recent experiences with exchanges on medicinal products, practices and experiences related to patient involvement, and compliance with post marketing activities. The minutes can be […]

Minutes from the EMA-EUnetHTA December 2018 Meeting now available

The minutes from the EMA-EUnetHTA Meeting, hosted by the European Medicines Agency on 7th December 2018, are now available for access. This was the 16th meeting between the EMA and EUnetHTA, with representatives from both organisations in attendance as well as attendance from the European Commission. In addition, payer organisations attended as observers. Agenda topics […]

The EUnetHTA Prioritisation List (EPL) 2.0 is now published and available for access

EUnetHTA is pleased to announce the publication of the second iteration of the EPL. As part of the overarching Topic Identitication, Selection and Prioritisation (TISP) task group, the EPL is a valuable strategic tool for companies to identify the significant interest of national HTA bodies in relation to specific listed compounds. EUnetHTA seeks to increase […]